BNB Surges to New All-Time High Despite Windtree Therapeutics Nasdaq Delisting

BNB surges to a new all-time high despite Windtree Therapeutics' Nasdaq delisting due to noncompliance with listing rules. The treasury company's stock plunged 76% after Nasdaq announced it will suspend trading effective Thursday. WINT plans to shift to OTC markets, while BNB continues its rally with a 5% gain over the past 24 hours.

Binance Coin (BNB) has reached a new all-time high, touching $880 on Wednesday, despite the Nasdaq delisting of Windtree Therapeutics (WINT). The treasury company's stock plunged 76% after Nasdaq announced it will suspend trading effective Thursday. Windtree Therapeutics plans to shift to over-the-counter (OTC) markets, while BNB continues its rally with a 5% gain over the past 24 hours.

The delisting announcement from Nasdaq stems from Windtree Therapeutics' noncompliance with Listing Rule 5550(a)(2), which requires firms on its Capital Market to maintain a minimum bid price of $1 per share for 30 consecutive business days. Despite this, BNB has shown resilience and continued its upward trajectory.

BNB's recent success is attributed to its expanding utility, deflationary design, and increasing institutional adoption. On Thursday, BNB marked its all-time high by surpassing $866. BNB's market capitalization has soared above $119 billion, overtaking global companies like Nike and SoftBank [1].

The token's utility in gas payments, staking, trading fee discounts, and DeFi and NFT uses has driven its growth. Several NASDAQ-listed companies are adopting BNB for their crypto treasury strategies. For instance, Windtree Therapeutics raised $520 million, with 99% allocated for BNB acquisitions, and Nano Labs is executing a $1 billion BNB strategy [1].

BNB's price predictions remain optimistic, with some analysts expecting even bigger boosts this year. The token's expanding utility and deflationary design support this optimism. In late July, it was reported that BNB surpassed Ethereum in having over 1% of its supply held in public company treasuries, further cementing its role as a corporate-grade asset [1].

Despite the challenges faced by Windtree Therapeutics, BNB has maintained its bullish momentum. The token's Relative Strength Index (RSI) and Stochastic Oscillator (Stoch) are close to their overbought regions, indicating heightened bullish pressure. Technical analysts are predicting a potential push toward $2,000 [1].

References:
[1] https://coinedition.com/how-bnbs-utility-institutional-backing-and-price-discovery-are-fueling-its-rally/
[2] https://www.fxstreet.com/cryptocurrencies/news/bnb-hits-new-all-time-high-even-as-treasury-company-windtree-therapeutics-faces-nasdaq-delisting-202508210032